Odyssey Therapeutics files for $100M IPO
Odyssey Therapeutics (ODTX), which is developing treatments for inflammatory bowel disease, has filed for a $100M initial ...
Microbiomes Market To Grow By USD 1.13 Billion (2024-2028), Driven By Rising Disease Prevalence AI Impact On Market Trends - Technavio
The Microbiomes Market is experiencing significant growth due to the increasing research and development in the field of ...
News Medical on MSN16h
Tofacitinib reduces SARS-CoV-2 infection risk in patients with PTPN2 deficiency
Researchers report the ability of tofacitinib to reduce infection risk with SARS-CoV-2 in individuals who are deficient in ...
US FDA Approves Omvoh For Severe Crohn’s Disease Relief: All You Need To Know
The FDA has approved Omvoh (mirikizumab-mrkz) for treating moderately to severely active Crohn’s disease in adults. Clinical ...
Science Daily4h
Your gut bacteria are in a chemical tug-of-war with your body
Our gut is a bustling hub of activity, home to trillions of microbes that work together with our bodies to keep us healthy. A recent study explores one fascinating aspect of this partnership: how gut ...
Science Daily6h
Wearable devices can detect and predict inflammatory bowel disease flare-ups
Wearable devices can identify, differentiate, and predict flare-ups, or the worsening of symptoms and inflammation, in inflammatory bowel disease (IBD), Mount Sinai researchers have shown in a ...
FDA approves Omvoh for moderately to severely active Crohn's disease
The U.S. Food and Drug Administration has approved Eli Lilly's Omvoh (mirikizumab-mrkz) for the treatment of moderately to ...
Healio8h
FDA approves therapies for colorectal cancer, mantle cell lymphoma
The FDA approved two oncology regimens on Jan. 16.One is for a subset of patients with colorectal cancer and the other for ...
Your cat’s poop can reveal a lot about it’s health
If you notice any of these abnormal cat poop characteristics or accompanying symptoms, consult with your veterinarian to ...